DAFNA Capital Management’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-112,414
| Closed | -$677K | – | 84 |
|
|
2024
Q4 | $677K | Hold |
112,414
| – | – | 0.17% | 69 |
|
|
2024
Q3 | $787K | Sell |
112,414
-8,937
| -7% | -$62.6K | 0.19% | 66 |
|
|
2024
Q2 | $704K | Sell |
121,351
-10,000
| -8% | -$58K | 0.17% | 68 |
|
|
2024
Q1 | $939K | Hold |
131,351
| – | – | 0.21% | 61 |
|
|
2023
Q4 | $646K | Buy |
131,351
+54,499
| +71% | +$268K | 0.15% | 63 |
|
|
2023
Q3 | $735K | Hold |
76,852
| – | – | 0.23% | 62 |
|
|
2023
Q2 | $996K | Buy |
76,852
+25,704
| +50% | +$333K | 0.27% | 53 |
|
|
2023
Q1 | $649K | Buy |
51,148
+35,500
| +227% | +$450K | 0.19% | 57 |
|
|
2022
Q4 | $180K | Buy |
+15,648
| New | +$180K | 0.05% | 74 |
|